Home > Press Releases

Press Releases (Page 28)

The Pennant Group Announces Director Changes

EAGLE, Idaho, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that Mr. Roderic W. Lewis notified the Board of Directors (the “Board”) that he intends to retire as a director of the company effective December 31, 2021. The Company also announced that the Board has appointed Gregory K.... ❯❯❯

Sage Institute for Psychedelic Therapy Announces Leadership Changes

OAKLAND, Calif., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Sage Institute for Psychedelic Therapy today announced that founding Executive Director Genesee Herzberg, PsyD, and Jason Butler, PhD, the Institute's training director and also a co-founder, have left the organization to pursue other professional interests and opportunities. With Dr. Herzberg’s departure, the executive committee of the board of directors has assumed her... ❯❯❯

Allarity Therapeutics Submits New Drug Application (NDA) to the U.S. FDA for Dovitinib for Third-Line Treatment of Renal Cell Carcinoma (RCC)

Marks Allarity’s first regulatory application for marketing approval for one of its prioritized oncology pipeline programs NDA is supported by Allarity’s previously-filed pre-market approval (PMA) submission to the FDA for the Dovitinib-DRP® companion diagnostic to select RCC patients most likely to respond to the drug Press release Cambridge, MA U.S.A. (December 22, 2021) — Allarity Therapeutics, Inc. (“Allarity”... ❯❯❯

MEDIROM Healthcare Technologies Inc. Announces Business Alliance with Juju Holdings Kabushiki Kaisha

NEW YORK, Dec. 21, 2021 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare Company based in Japan (the “Company” or “MEDIROM”), today announced that MEDIROM has signed a Memorandum of Understanding (the “MOU”) with Juju Holdings Kabushiki Kaisha (“Juju Holdings”), an operator of home-based nursing care facilities in Japan, to form a business alliance to jointly develop a... ❯❯❯

Allarity Therapeutics Closes Its Recapitalization, Share Exchange, and $20M PIPE Investment; Lists on U.S. Nasdaq Stock Market

Press release         Cambridge, MA U.S.A. (December 21, 2021) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a clinical-stage biopharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, today announced the closing of its Recapitalization Share Exchange resulting in its initial public listing of 8,075,824 shares of... ❯❯❯

Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. Uihlein

NORCROSS, Ga., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on the second $10 million convertible note pursuant to a financing agreement entered in September, 2021, with Richard E. Uihlein, the Company’s Chairman and largest individual stockholder. In total, the Company has received $30 million in... ❯❯❯

Extendicare Announces December 2021 Dividend of C$0.04 per Share

MARKHAM, Ontario, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of December 2021, which is payable on January 17, 2022 to shareholders of record at the close of business on December 31, 2021. This dividend is designated as an “eligible dividend”... ❯❯❯

Treatment Signs Ocean Medical Agreement For The AI Driven Doctors Office

VANCOUVER, British Columbia, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment or the (“Company”) (CSE: TRUE • OTC: TREIF • 939.F) is a healthcare technology company with a passion for supporting consumers and health care providers globally with easy, AI-driven solutions. Today Treatment announces the first sale of its Treatment Primary Care Module, powering the next generation of... ❯❯❯

Sienna Announces December Dividend

MARKHAM, Ontario, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of December 2021, representing $0.936 per Common Share on an annualized basis. The dividend will be payable on January 14, 2022 to shareholders of record as at December 31, 2021. The Company's... ❯❯❯

SeaSpine Appoints Seasoned Healthcare Executive to its Board of Directors

CARLSBAD, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has appointed Angela Steinway to its Board of Directors, effective December 14, 2021. Ms. Steinway will serve as a member of the company’s Audit Committee. With the appointment of Ms. Steinway, the SeaSpine... ❯❯❯